Legal & General Group’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $45.7K | Buy |
4,140
+808
| +24% | +$8.91K | ﹤0.01% | 2732 |
|
|
2025
Q1 | $29.8K | Sell |
3,332
-37,886
| -92% | -$338K | ﹤0.01% | 2817 |
|
|
2024
Q4 | $388K | Sell |
41,218
-12,857
| -24% | -$121K | ﹤0.01% | 2549 |
|
|
2024
Q3 | $436K | Hold |
54,075
| – | – | ﹤0.01% | 2514 |
|
|
2024
Q2 | $459K | Buy |
54,075
+1,656
| +3% | +$14K | ﹤0.01% | 2446 |
|
|
2024
Q1 | $470K | Buy |
52,419
+2,025
| +4% | +$18.2K | ﹤0.01% | 2453 |
|
|
2023
Q4 | $566K | Sell |
50,394
-4,987
| -9% | -$56.1K | ﹤0.01% | 2403 |
|
|
2023
Q3 | $478K | Sell |
55,381
-1,815
| -3% | -$15.7K | ﹤0.01% | 2460 |
|
|
2023
Q2 | $592K | Buy |
57,196
+401
| +0.7% | +$4.15K | ﹤0.01% | 2405 |
|
|
2023
Q1 | $616K | Buy |
56,795
+1,404
| +3% | +$15.2K | ﹤0.01% | 2269 |
|
|
2022
Q4 | $621K | Sell |
55,391
-468
| -0.8% | -$5.25K | ﹤0.01% | 2285 |
|
|
2022
Q3 | $566K | Sell |
55,859
-3,045
| -5% | -$30.9K | ﹤0.01% | 2314 |
|
|
2022
Q2 | $534K | Buy |
58,904
+1,516
| +3% | +$13.7K | ﹤0.01% | 2321 |
|
|
2022
Q1 | $549K | Sell |
57,388
-9
| -0% | -$86 | ﹤0.01% | 2372 |
|
|
2021
Q4 | $634K | Buy |
57,397
+14,648
| +34% | +$162K | ﹤0.01% | 2345 |
|
|
2021
Q3 | $316K | Buy |
42,749
+11,224
| +36% | +$83K | ﹤0.01% | 2551 |
|
|
2021
Q2 | $458K | Buy |
31,525
+461
| +1% | +$6.7K | ﹤0.01% | 2353 |
|
|
2021
Q1 | $634K | Sell |
31,064
-201
| -0.6% | -$4.1K | ﹤0.01% | 2270 |
|
|
2020
Q4 | $555K | Hold |
31,265
| – | – | ﹤0.01% | 2236 |
|
|
2020
Q3 | $463K | Sell |
31,265
-2,230
| -7% | -$33K | ﹤0.01% | 2218 |
|
|
2020
Q2 | $703K | Sell |
33,495
-493
| -1% | -$10.3K | ﹤0.01% | 2087 |
|
|
2020
Q1 | $785K | Buy |
33,988
+9,048
| +36% | +$209K | ﹤0.01% | 1930 |
|
|
2019
Q4 | $646K | Buy |
24,940
+1,762
| +8% | +$45.6K | ﹤0.01% | 2168 |
|
|
2019
Q3 | $452K | Buy |
23,178
+2,388
| +11% | +$46.6K | ﹤0.01% | 2179 |
|
|
2019
Q2 | $339K | Buy |
20,790
+500
| +2% | +$8.15K | ﹤0.01% | 2220 |
|
|
2019
Q1 | $460K | Buy |
20,290
+1,046
| +5% | +$23.7K | ﹤0.01% | 2172 |
|
|
2018
Q4 | $492K | Buy |
19,244
+5,502
| +40% | +$141K | ﹤0.01% | 2120 |
|
|
2018
Q3 | $449K | Hold |
13,742
| – | – | ﹤0.01% | 2169 |
|
|
2018
Q2 | $312K | Sell |
13,742
-1,139
| -8% | -$25.9K | ﹤0.01% | 2212 |
|
|
2018
Q1 | $361K | Sell |
14,881
-6,259
| -30% | -$152K | ﹤0.01% | 2186 |
|
|
2017
Q4 | $591K | Buy |
21,140
+2,300
| +12% | +$64.3K | ﹤0.01% | 2057 |
|
|
2017
Q3 | $646K | Buy |
18,840
+2,551
| +16% | +$87.5K | ﹤0.01% | 2020 |
|
|
2017
Q2 | $649K | Buy |
16,289
+576
| +4% | +$22.9K | ﹤0.01% | 1981 |
|
|
2017
Q1 | $576K | Buy |
15,713
+1,631
| +12% | +$59.8K | ﹤0.01% | 1998 |
|
|
2016
Q4 | $448K | Buy |
+14,082
| New | +$448K | ﹤0.01% | 2013 |
|